Skip redundant pieces
University of Kansas Cancer Center
University of Kansas Cancer Center  :  Leadership

Gary C. Doolittle, MD


G DoolittleMedical Director, Midwest Cancer Alliance
Capitol Federal Masonic Distinguished Professorship in Cancer
gdoolittle@kumc.edu

Gary Doolittle, MD leads the effort to enhance cancer care throughout the state and region through the Midwest Cancer Alliance, the outreach arm of the University of Kansas Cancer Center.  As the Medical Director of the MCA, Dr. Doolittle oversees the recruitment of members and the vision for providing access to cutting-edge clinical trials and the latest advancements in cancer care to people in their own communities throughout the Heartland Region. 

Dr. Doolittle serves as professor of medicine in the Division of Hematology/Oncology, specializing in melanoma malignancies.  He has been instrumental in developing and providing consultation services for KUMC’s Center for Tele-medicine and Tele-health through the Tele-oncology program.   

Dr. Doolittle joined the faculty of the University of Kansas Medical Center in 1991.  In 2007, he was named Medical Director of the Midwest Cancer Alliance.

Background

Dr. Doolittle is a native of Kansas and received his undergraduate degree from Pittsburg State University in 1980.  He went on to complete his Medical Degree from the University of Kansas School of Medicine.  Dr. Doolittle has served as the Medical Director of the University of Kansas Medical Center’s Center for Telemedicine since 2000. 

He has an oncology outreach clinic at Hays Medical Center in Hays, Kansas, where he travels to twice a month. He also has an oncology outreach clinic at the Northeast Kansas Center for Health and Wellness in Horton, Kansas that he travels to once a month. 

Membership Organizations

  • Member, American College of Physicians
  • Member, American Society of Clinical Oncology
  • Member, American Society of Hematology
  • Member, American Telemedicine Association

Recent Publications

  1. Whitten P, Doolittle GC, Mackert, M.  Telehospice in Michigan: Use and patient acceptance.  Am J Hosp Palliat Care.  2004;21(3):L191-195.
  2. Clemens C, Doolittle GC, Sypher B.  The role of telehospice in end-of-life care.  In: Whitten P, Cook DJ, eds.  Understanding Health Communication Technologies: A Case Book Approach.  Indianapolis, IN: Jossey-Bass; 2004:111-117.
  3. Doolittle GC, Spaulding A, Spaulding RJ.  The financial side of a Kansas tele-oncology practice.  In: Whitten P, Cook DJ, eds.  Understanding Health Communication Technologies: A Case Book Approach.  Indianapolis, IN: Jossey-Bass; 2004:171-177.
  4. Doolittle GC, Spaulding A.  Online cancer services: Types of services offered and associated health outcomes.  J Med Internet Res.  2005;7(3):e35.
  5. Doolittle GC, Whitten P, McCartney M, Cook DJ, Nazir N.  An empirical chart analysis of the suitability of telemedicine for hospice visits.  Telemed J E Health.  2005;11(1):90-97.
  6. Spaulding RJ, Russo T, Cook DJ, Doolittle GC.  Diffusion theory and telemedicine adoption by Kansas health-care providers: Critical factors in telemedicine adoption for improved patient access.  J Telemed Telecare.  2005;11(Suppl 1):107-109.
  7.  Smith CE, Dauz ER, Clements F, Puno FN, Cook D, Doolittle G, Leeds W.  Telehealth services to improve nonadherence:  A placebo-controlled study.  Telemed J E Health, 2006 Jun; 12(3) 289-96.
  8. Doolittle GC, Spaulding R :  Defining the needs of a telemedicine service.  Journal of Telemedicine and Telecare, 2006; 12 (6) 276-284.
  9. Doolittle GC, Spaulding AO. Providing Access to Oncology Care for Rural Patients via Telemedicine  Journal of Oncology Practice  Vol 2 Issue 5  Sept. 2006.
  10. Whitten P, Doolittle GC, Mackert M.  Providers’ acceptance of telehospice.  J Palliat Med.  In press.